BioCardia Announces United States Patent Issuance on Intramyocardial Delivery of Cell Aggregates to the Heart Including Minimally Invasive Radial Artery Approach
June 07, 2024 07:00 ET
|
BioCardia, Inc.
BioCardia announces that the USPTO has granted Patent No: 11,986,611 titled “Radial and Transendocardial Delivery Catheter,” with a 2036 expiration date.
CBIH and Vita Biotech Forge Alliance to Propel Clinical Studies Forward
June 05, 2024 15:12 ET
|
CANNABIS BIOSCIENCE INTERNATIONAL HOLDINGS, INC.
“Collaboration in clinical trials ensures data integrity and safety, advancing both organizations' missions and improving patient care,” says Dr. Jennifer
Axsome Therapeutics Settles Sunosi® (solriamfetol) Patent Litigation with Unichem Laboratories
June 05, 2024 07:35 ET
|
Axsome Therapeutics, Inc.
NEW YORK, June 05, 2024 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM) (Axsome), a biopharmaceutical company developing and delivering novel therapies for the management of central...
MediciNova Receives Notice of Allowance for New Patent Covering MN-166 (ibudilast) for the Prevention of Metastasis of Various Solid Cancer
June 05, 2024 06:00 ET
|
MediciNova, Inc.
LA JOLLA, Calif., June 05, 2024 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market of the Tokyo Stock Exchange...
VoIP-Pal Files New Patent Infringement Against Lawsuits Against Verizon, and T-Mobile, Asserting its RBR Patents in U.S. District Court for the Western District of Texas, Waco Division
June 03, 2024 08:00 ET
|
Voip-Pal.Com Inc.
VoIP-Pal files new patent infringment lawsuits in the Western District of Texas against Verizon and T-Mobile asserting its RBR and RBR messaging patents
Vidac Pharma receives US patent office Notice of Allowance for crucial compounds in its cancer drug candidates
June 03, 2024 01:30 ET
|
Vidac Pharma Holding PLC
London (UK), June 3, 2024 (07:30 CET) – Vidac Pharma Holdings Plc. (Hamburg and Stuttgart: T9G; ISIN:GB00BM9XQ619; WKN: A3DTUQ), a clinical-stage oncology biopharmaceutical company pioneering a novel...
Vicor patents asserted against infringing NBMs withstand validity challenges
May 28, 2024 15:53 ET
|
Vicor Corporation
ANDOVER, Mass., May 28, 2024 (GLOBE NEWSWIRE) -- Vicor Corporation (NASDAQ: VICR) today announced that the Patent Trial and Appeal Board (“PTAB”) of the United States Patent and Trademark Office...
Medigene AG Expands its End-to-End Platform by Submitting Three Development Optimization Technology Patents to the European Patent Office
May 28, 2024 03:00 ET
|
Medigene AG
Planegg/Martinsried, May 28, 2024 – Medigene AG (Medigene or the “Company”, FSE: MDG1, Prime Standard), an immuno-oncology platform company focusing on the discovery and development of T cell...
Update: Trust Stamp announces that it is filing a patent for an AI-based Age Estimation Calibration Algorithm
May 23, 2024 13:59 ET
|
Trust Stamp
ATLANTA, GA, May 23, 2024 (GLOBE NEWSWIRE) -- Trust Stamp (Nasdaq: IDAI), the AI-powered, Privacy First Identity CompanyTM announces that it is filing a patent for an AI-powered process that...
Trust Stamp files provisional patent for AI-based Age Estimation Calibration Algorithm, its 14th pending patent
May 23, 2024 13:04 ET
|
Trust Stamp
Atlanta, GA, May 23, 2024 (GLOBE NEWSWIRE) -- Trust Stamp (Nasdaq: IDAI), the AI-powered, Privacy First Identity CompanyTM announces that it is filing a patent for an AI-powered process that...